Japan Pharmaceutical industry registered 5.79% growth in 2011

Feb. 12, 2012 - PRLog -- Japan is the second largest market for pharmaceuticals, accounting for 11.20% share in global pharmaceutical industry. The impact of recent economic turmoil was not grave over domestic pharmaceutical companies due to increase in value of Japanese currency against USD. Japanese pharmaceutical industry is facing a strong competition from China. In coming years, the strict government regulations, changing policies and restrictions on imports in Japan will allow Chinese pharmaceutical industry outpace Japan.
Drug stores, hospitals and clinics account for the largest demand for pharmaceuticals while supermarkets and other confectionary stores (permitted to keep general cold and flu medicines) account for only a small percentage of demand. Pharmacies and drug stores hold 51.30% share in terms of sales of pharmaceuticals followed by hospitals and clinics.
In 2010, Japanese pharmaceutical industry recorded USD ~ billion revenues and grew by 5.79% in 2011. The recent Tsunami affected production units of some drug manufacturers, leading to fall in production of certain medicines to treat cancer, ADHD, and other medical conditions which caused several hospitals to delay their treatment. Expiry of patents of many medicines due in 2011 & 2012 are also expected to affect the growth rate further.
The present report entitled “Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs Market”, discuss market size (historical, present and future) of the Japanese pharmaceutical industry and its segments. Drugs market has been categorized by distribution channels (OTC & Prescription drugs) and by type of drugs (Patent & Generic). Report also provides information on recent trends including M&A’s, regulatory structure and key issues. Report discusses major drivers promising future growth. The competition prevailing in the pharmaceutical market has also been included in the report with profile of the major players, highlighting their financials as well as growth strategies. The report also talks about future outlook of overall Japanese Pharmaceutical industry and demand for prescription and OTC drugs in coming years.
Japanese pharmaceutical industry is expected to grow at a slow rate due to government reforms in healthcare policy aiming to control rising healthcare cost and uneven demand from outside Japan. The Japanese digestive medicines segment is witnessing a continuous fall in shipment by volume and value from last four years (2007-2010). Vitamins, Antiallergic, skincare and Antibiotics will push the OTC drugs demand which currently account for a small share of the overall pharmaceutical industry in Japan. OTC drugs market is expected to grow at CAGR 6.22% from 2011-2016. Industry consolidation is expected to continue, led by falling drug prices and increasing competition from foreign companies.
Key Findings

   In the first quarter of 2010, the global advertising expenditures on pharmaceutical products grew 3.60% compared to the same period in 2009.
   Pharmacies and drug stores hold 51.30% share in terms of sales of pharmaceuticals followed by hospitals and clinics.
   In 2009, pharmaceuticals market in the country grew 8.67% to USD ~ billion. This growth was mainly driven by the treatment of chronic diseases and government healthcare spending.
   In 2010, Japanese pharmaceutical industry recorded USD ~ billion revenues and grew by 5.79% in 2011.
   The Japanese pharmaceutical industry is expected to grow at a CAGR 2.65% from 2011 to 2016 reaching USD ~ billion.
   In 2011, OTC market grew by 4.26% from previous year and its share in total pharmaceutical drugs market reached 6.98% although this percentage was low from 2010 results.
   The overall prescription drugs sales is expected to register slow growth reaching USD ~ billion by 2016 at a CAGR 2.39% from 2011-2016.
   In Japan, generic drug market is in development stage, presently accounted for only 22.60% (by volume) and 6.75% (by value) of the total drug sales in 2010.

For more information please refer to the below mentioned link:
http://ammindpower.com/report.php?A=244

# # #

Founded in 2007, AM Mindpower Solutions is a leading market research and information service provider in India. The company offers industry research, company profiles and Mergers & Acquisitions, Private Equity and Venture capital deal directories to the clients across a spectrum of industries.
We gather information from a wide range of sources using advanced information management tools, sophisticated analytical systems and methodologies and dedicated professional client services.
We are committed to the highest levels of professional standards and conduct and engage with the clients in developing an understanding of the various industries – segments and sub-segments, companies, competitors and suppliers.
AM Mindpower’s high quality research and analytics services can be assessed by the fact that most of its business is from repeat clients.